DK1616012T3 - Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser deraf - Google Patents
Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser derafInfo
- Publication number
- DK1616012T3 DK1616012T3 DK04728627T DK04728627T DK1616012T3 DK 1616012 T3 DK1616012 T3 DK 1616012T3 DK 04728627 T DK04728627 T DK 04728627T DK 04728627 T DK04728627 T DK 04728627T DK 1616012 T3 DK1616012 T3 DK 1616012T3
- Authority
- DK
- Denmark
- Prior art keywords
- applications
- lentiviral vectors
- vectors bearing
- bidirectional promoters
- synthetic bidirectional
- Prior art date
Links
- 230000002457 bidirectional effect Effects 0.000 title abstract 3
- 239000013598 vector Substances 0.000 title 1
- 210000004102 animal cell Anatomy 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
- C12N2830/205—Vector systems having a special element relevant for transcription transcription of more than one cistron bidirectional
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46508003P | 2003-04-24 | 2003-04-24 | |
PCT/IT2004/000227 WO2004094642A2 (en) | 2003-04-24 | 2004-04-21 | Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1616012T3 true DK1616012T3 (da) | 2008-04-21 |
Family
ID=33310991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04728627T DK1616012T3 (da) | 2003-04-24 | 2004-04-21 | Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser deraf |
Country Status (10)
Country | Link |
---|---|
US (1) | US8501464B2 (de) |
EP (1) | EP1616012B1 (de) |
JP (1) | JP2006524051A (de) |
AT (1) | ATE381620T1 (de) |
AU (1) | AU2004233315A1 (de) |
CA (1) | CA2523138C (de) |
DE (1) | DE602004010799T2 (de) |
DK (1) | DK1616012T3 (de) |
ES (1) | ES2298745T3 (de) |
WO (1) | WO2004094642A2 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2609142C (en) | 2005-05-27 | 2016-02-09 | Fondazione Centro San Raffaele Del Monte Tabor | Therapeutic gene vectors comprising mirna target sequences |
EP2188386A2 (de) * | 2007-09-17 | 2010-05-26 | Universite De Strasbourg | Verfahren für den nachweis oder die quantifizierung einer verkürzten mutation |
WO2010075956A1 (de) | 2008-12-16 | 2010-07-08 | C-Lecta Gmbh | Expressionsvektor |
US8728458B2 (en) | 2009-04-30 | 2014-05-20 | The Regents Of The University Of California | Combination anti-HIV vectors, targeting vectors, and methods of use |
US9719146B2 (en) * | 2009-09-09 | 2017-08-01 | General Electric Company | Composition and method for imaging stem cells |
US8956828B2 (en) * | 2009-11-10 | 2015-02-17 | Sangamo Biosciences, Inc. | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
CN101851637B (zh) * | 2010-01-15 | 2011-12-14 | 中国农业科学院北京畜牧兽医研究所 | 一种制备同时表达多个基因的转基因动物的方法 |
WO2012004778A1 (en) * | 2010-07-09 | 2012-01-12 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for in-vitro monitoring of neuronal disorders and use thereof |
US8945876B2 (en) | 2011-11-23 | 2015-02-03 | University Of Hawaii | Auto-processing domains for polypeptide expression |
EP4223772A3 (de) | 2013-02-15 | 2023-10-18 | Bioverativ Therapeutics Inc. | Optimiertes faktor-viii-gen |
JP6346266B2 (ja) | 2013-03-21 | 2018-06-20 | サンガモ セラピューティクス, インコーポレイテッド | 操作されたジンクフィンガータンパク質ヌクレアーゼを使用するt細胞受容体遺伝子の標的化された破壊 |
EP3160478A4 (de) | 2014-06-30 | 2018-05-16 | Bioverativ Therapeutics Inc. | Optimiertes faktor-ix-gen |
EP3283634B1 (de) * | 2015-04-14 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Rekombinantes adenovirus mit expression von zwei transgenen mit einem bidirektionalen promotor |
WO2017096363A1 (en) * | 2015-12-04 | 2017-06-08 | Board Of Regents, The University Of Texas System | Reporter system for detecting and targeting activated cells |
PT3411478T (pt) | 2016-02-01 | 2022-09-13 | Bioverativ Therapeutics Inc | Genes do fator viii otimizados |
AU2017254665C1 (en) * | 2016-04-20 | 2021-03-11 | Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. | Compositions and methods for enhanced gene expression of PKLR |
KR101864581B1 (ko) * | 2016-11-04 | 2018-07-13 | 국립암센터 | 양방향 프로모터를 포함하는 렌티바이러스 발현 벡터 및 이의 용도 |
EP3346001A1 (de) | 2017-01-06 | 2018-07-11 | TXCell | Monospezifische regulatorische t-zellpopulation mit zytotoxizität gegenüber b-zellen |
WO2018127585A1 (en) | 2017-01-06 | 2018-07-12 | Txcell | Monospecific regulatory t cell population with cytotoxicity for b cells |
CA3072334A1 (en) | 2017-08-09 | 2019-02-14 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof |
US11814432B2 (en) | 2017-09-20 | 2023-11-14 | The University Of British Columbia | Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof |
CN111163810A (zh) | 2017-10-16 | 2020-05-15 | 能源环境和技术研究中心O.A., M.P. | 用于递送pklr以治疗丙酮酸激酶缺乏症的慢病毒载体 |
WO2019118508A1 (en) * | 2017-12-12 | 2019-06-20 | The Trustees Of The University Of Pennsylvania | Genetically modified immune cells targeting ny-eso-1 and methods of use thereof |
BR112020015228A2 (pt) | 2018-02-01 | 2020-12-29 | Bioverativ Therapeutics Inc. | Uso de vetores lentivirais que expressam fator viii |
CN112292400A (zh) | 2018-04-13 | 2021-01-29 | 桑格摩生物治疗法国公司 | 对白介素-23受体特异的嵌合抗原受体 |
MX2021001599A (es) | 2018-08-09 | 2021-07-02 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y sus usos para la terapia genica no viral. |
CA3109253A1 (en) | 2018-08-10 | 2020-02-13 | Sangamo Therapeutics France | New car constructs comprising tnfr2 domains |
WO2020081759A1 (en) * | 2018-10-17 | 2020-04-23 | Texas Tech University System | Multivalent virus like particle vaccines |
GB201817821D0 (en) | 2018-10-31 | 2018-12-19 | Ospedale San Raffaele Srl | TCR and peptides |
EP3884056A1 (de) * | 2018-11-20 | 2021-09-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Zur behandlung des ipex-syndroms geeignete rekombinante vektoren |
WO2020118069A2 (en) | 2018-12-06 | 2020-06-11 | Bioverativ Therapeutics Inc. | Use of lentiviral vectors expressing factor ix |
CN115279896A (zh) | 2019-09-30 | 2022-11-01 | 比奥维拉迪维治疗股份有限公司 | 慢病毒载体配制品 |
EP3808766A1 (de) | 2019-10-15 | 2021-04-21 | Sangamo Therapeutics France | Interleukin-23-rezeptor-spezifischer chimärer antigen-rezeptor |
CA3168089A1 (en) * | 2020-02-13 | 2021-08-19 | Rosa Bacchetta | Crispr-based foxp3 gene engineered t cells and hematopoietic stem cell precursors to treat ipex syndrome patients |
CA3172120A1 (en) | 2020-03-20 | 2021-09-23 | Inserm (Institut De La Sante Et De La Recherche Medicale) | Chimeric antigen receptor specific for human cd45rc and uses thereof |
IL299333A (en) | 2020-06-24 | 2023-02-01 | Bioverativ Therapeutics Inc | Methods for the purification of viral vectors |
AU2021320902A1 (en) | 2020-08-07 | 2023-04-06 | Spacecraft Seven, Llc | Plakophilin-2 (PKP2) gene therapy using AAV vector |
IL300445A (en) | 2020-08-23 | 2023-04-01 | Bioverativ Therapeutics Inc | A baculovirus system adapted to improve the production of closed-end DNA (cadna) |
CN113106091B (zh) * | 2021-03-04 | 2022-08-16 | 杭州师范大学 | 一种植物叶片高表达双向启动子及其应用 |
IL310997A (en) | 2021-08-23 | 2024-04-01 | Bioverativ Therapeutics Inc | Factor VIII gene optimization |
WO2023028440A2 (en) | 2021-08-23 | 2023-03-02 | Bioverativ Therapeutics Inc. | Baculovirus expression system |
WO2023035002A1 (en) | 2021-09-03 | 2023-03-09 | Sangamo Therapeutics, Inc. | Mog-binding proteins and uses thereof |
CA3232988A1 (en) | 2021-09-30 | 2023-04-06 | Bioverativ Therapeutics Inc. | Nucleic acids encoding factor viii polypeptides with reduced immunogenicity |
KR102632204B1 (ko) * | 2022-03-24 | 2024-02-02 | (주)셀레브레인 | 신규 재조합 벡터 및 이의 용도 |
WO2023182870A1 (ko) * | 2022-03-24 | 2023-09-28 | (주)셀레브레인 | 신규 재조합 벡터 및 이의 용도 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
US6136597A (en) * | 1997-09-18 | 2000-10-24 | The Salk Institute For Biological Studies | RNA export element |
CA2314683A1 (en) | 1997-12-12 | 1999-06-24 | Luigi Naldini | Therapeutic use of lentiviral vectors |
CN1281512A (zh) | 1997-12-12 | 2001-01-24 | 昂尼克斯药物公司 | p53+肿瘤细胞的选择性杀伤和诊断 |
JP2002530070A (ja) | 1998-11-13 | 2002-09-17 | セル ジェネシス インコーポレイテッド | エンベロープ欠損組換えウイルスについての感度のよいスクリーニング系。 |
CA2803417A1 (en) | 1998-11-13 | 2000-05-25 | Gbp Ip, Llc | Selection system for generating efficient packaging cells for lentiviral vectors |
WO2000066769A2 (en) | 1999-04-30 | 2000-11-09 | Advance Sentry Corporation | System and method for screening of nasopharyngeal carcinoma |
US6630324B1 (en) * | 1999-07-29 | 2003-10-07 | Baylor College Of Medicine | Aldehyde reductase bidirectional promoter and its use |
US6780639B1 (en) * | 1999-08-24 | 2004-08-24 | Universite Libre De Bruxelles | Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
AU2001278430A1 (en) | 2000-05-22 | 2001-12-03 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Systemic and cardiovascular transduction with lentiviral vectors |
JP2003033179A (ja) * | 2001-07-05 | 2003-02-04 | Asahi Kasei Corp | 可逆的遺伝子導入ベクター |
EP1497439B1 (de) * | 2002-04-15 | 2006-09-06 | Universitätsklinikum Hamburg-Eppendorf | Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression |
-
2004
- 2004-04-21 ES ES04728627T patent/ES2298745T3/es not_active Expired - Lifetime
- 2004-04-21 AU AU2004233315A patent/AU2004233315A1/en not_active Abandoned
- 2004-04-21 CA CA2523138A patent/CA2523138C/en not_active Expired - Lifetime
- 2004-04-21 US US10/554,181 patent/US8501464B2/en active Active
- 2004-04-21 EP EP04728627A patent/EP1616012B1/de not_active Expired - Lifetime
- 2004-04-21 DE DE602004010799T patent/DE602004010799T2/de not_active Expired - Lifetime
- 2004-04-21 DK DK04728627T patent/DK1616012T3/da active
- 2004-04-21 WO PCT/IT2004/000227 patent/WO2004094642A2/en active IP Right Grant
- 2004-04-21 AT AT04728627T patent/ATE381620T1/de not_active IP Right Cessation
- 2004-04-21 JP JP2006507649A patent/JP2006524051A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1616012A2 (de) | 2006-01-18 |
WO2004094642A3 (en) | 2005-05-12 |
DE602004010799D1 (de) | 2008-01-31 |
US20060200869A1 (en) | 2006-09-07 |
JP2006524051A (ja) | 2006-10-26 |
CA2523138C (en) | 2013-04-23 |
CA2523138A1 (en) | 2004-11-04 |
ES2298745T3 (es) | 2008-05-16 |
US8501464B2 (en) | 2013-08-06 |
AU2004233315A1 (en) | 2004-11-04 |
DE602004010799T2 (de) | 2009-01-22 |
ATE381620T1 (de) | 2008-01-15 |
EP1616012B1 (de) | 2007-12-19 |
WO2004094642A2 (en) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1616012T3 (da) | Lentivirale vektorer bærende syntetiske bidirektionelle promotorer og anvendelser deraf | |
ATE517992T1 (de) | Funktionelle und hyperfunktionelle sirna | |
BRPI0417825A (pt) | métodos para uso de lactobacilli probióticos para animais de estimação | |
BRPI0417823A (pt) | métodos para uso de bifidobactérias probióticas para animais de estimação | |
ATE393169T1 (de) | Il-7-fusionsproteine mit antikörperportionen, deren herstellung und deren verwendung | |
CY1110557T1 (el) | Αντισωματα ιντερλευκινης-10 | |
DK1546316T3 (da) | Mutant E. Coli-AppA-fytaseenzymer og naturlige varianter deraf, nukleinsyrer, der koder for sådanne fytaseenzymer, vektorer og værtsceller, som inkorporerer disse og fremgangsmåder til at fremstille og anvende disse | |
DK1131444T3 (da) | Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse | |
CY1110868T1 (el) | Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση | |
DK1585737T3 (da) | Uraciler med herbicid virkning | |
DE60031395D1 (de) | Mikrobielle beta-glukuronidase gene, genprodukte und deren verwendungen | |
DE60325611D1 (de) | Benzoat- und antranilatinduzierbare promotoren | |
ES2421558T3 (es) | Anticuerpos específicos de cáncer y proteínas de superficie celular | |
ATE352228T1 (de) | Bürstenanordnung | |
NZ334839A (en) | Polynucleotide molecules encoding neospora proteins and uses thereof | |
DE60025704D1 (de) | Das goodpasture-antigen bindende protein | |
ATE404602T1 (de) | Wässrige polyurethanzubereitungen | |
BRPI0308119A2 (pt) | microorganismo como portadores de seqüências de nucleotídeos codificando para antígenos de células para o tratamento de tumores. | |
ATE429443T1 (de) | Nukleinsäuresequenz, die für das opca gen kodiert | |
SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
CY1109904T1 (el) | Προαγωγεας της il-18bp, η παρασκευη και χρηση του | |
WO2003091447A3 (en) | D1-1 nucleic acids, polypeptides and related methods | |
ATE550311T1 (de) | Treibladung | |
RU2003103720A (ru) | Штамм бактерий bacillus pantothenticus 1-85 для использования в гранулированных кормах | |
ATE334215T1 (de) | Verwendung des aminoglycosidresistenzgens |